1. DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment

   • Momir Mikov
   • Nebojša Pavlović
   • Hani Al-Salami

   Review Article 05 August 2019 Pages: 1 - 14

2. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor

   • Leduo Zhang
   • Yu Mao
   • Guangxin Xia

   Original Research Article 07 September 2019 Pages: 15 - 26

   

3. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

   • Daniela Willen
   • Wolfgang Uhl
   • Özkan Yalkinoglu

   Original Research Article Open access 16 September 2019 Pages: 27 - 40

   

4. Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease

   • Murshid Saqlain
   • Moudud Alam
   • Jerker Westin

   Original Research Article Open access 08 October 2019 Pages: 41 - 49

   

5. Excretion, Metabolism and Cytochrome P450 Inhibition of Methyl 3,4-Dihydroxybenzoate (MDHB): A Potential Candidate to Treat Neurodegenerative Diseases

   • Jia Hui Wang
   • Ke Qi Chen
   • Huan Min Luo

   Original Research Article 10 October 2019 Pages: 51 - 69

   

6. Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers

   • Šárka Studená
   • Eva Doleželová
   • Jaroslav Chládek

   Original Research Article 11 October 2019 Pages: 71 - 80

   

7. Influence of MAMA decoction, an Herbal Antimalarial, on the Pharmacokinetics of Amodiaquine in Mice

   • Awodayo O. Adepiti
   • Babatunde A. Adeagbo
   • Anthony A. Elujoba

   Original Research Article 22 October 2019 Pages: 81 - 88

   

8. Development and Validation of a New LC–MS/MS Analytical Method for Direct-Acting Antivirals and Its Application in End-Stage Renal Disease Patients

   • Faten Farouk
   • Dina Wahba
   • Salwa Ibahim

   Original Research Article 30 October 2019 Pages: 89 - 99

   

9. Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug–Drug Interaction Study

   • Italo Poggesi
   • Lilian Y. Li
   • Daniele Ouellet

   Original Research Article 31 October 2019 Pages: 101 - 111

   

10. Glucose-Responsive Microspheres as a Smart Drug Delivery System for Controlled Release of Insulin

    • Jiaojiao Yu
    • Qiongyan Wang
    • Liandong Hu

    Original Research Article 01 November 2019 Pages: 113 - 121

    

11. High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation

    • Maaike A. Sikma
    • Claudine C. Hunault
    • Dylan W. De Lange

    Original Research Article Open access 19 November 2019 Pages: 123 - 134

    

12. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population

    • Ren Zhang
    • Ming Chen
    • Chun-le Lv

    Original Research Article 20 September 2019 Pages: 135 - 149

    

13. Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective

    • Guo Yu
    • Guo-Fu Li

    Commentary 06 November 2019 Pages: 151 - 156